TY - JOUR
T1 - Alternatives to autograft evaluated in a rabbit segmental bone defect
AU - McDaniel, Jennifer S.
AU - Pilia, Marcello
AU - Raut, Vivek
AU - Ledford, Jeffrey
AU - Shiels, Stefanie M.
AU - Wenke, Joseph C.
AU - Barnes, Brian
AU - Rathbone, Christopher R.
N1 - Publisher Copyright:
© 2015, SICOT aisbl (outside the USA).
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Purpose: This study was designed to identify strategies for treating bone defects that can be completed on the day of surgery. Methods: Forty New Zealand white rabbits with unilateral rabbit radius segmental defects (15 mm) were treated with commercially available scaffolds containing either demineralised bone matrix (DBM) or a collagen/beta-tricalcium phosphate composite (Col:β-TCP); each scaffold was combined with either bone marrow aspirate (BMA) or concentrated BMA (cBMA). Bone regeneration was assessed through radiographic and histological analyses. Results: The concentration of nucleated cells, colony-forming unit-fibroblasts and platelets were increased and haematocrit concentration decreased in cBMA as compared to BMA (p < 0.05). Radiographic analyses of bone formation and defect bridging demonstrated significantly greater bone regeneration in the defects treated with DBM grafts as compared to Col:β-TCP grafts. The healing of bones treated with Col:β-TCP was improved when augmented with cBMA. Conclusions: Scaffolds containing either DBM or Col:β-TCP with BMA or cBMA are effective same-day strategies available to clinicians for the treatment of bone defects; the latter scaffold may be more effective if combined with cBMA.
AB - Purpose: This study was designed to identify strategies for treating bone defects that can be completed on the day of surgery. Methods: Forty New Zealand white rabbits with unilateral rabbit radius segmental defects (15 mm) were treated with commercially available scaffolds containing either demineralised bone matrix (DBM) or a collagen/beta-tricalcium phosphate composite (Col:β-TCP); each scaffold was combined with either bone marrow aspirate (BMA) or concentrated BMA (cBMA). Bone regeneration was assessed through radiographic and histological analyses. Results: The concentration of nucleated cells, colony-forming unit-fibroblasts and platelets were increased and haematocrit concentration decreased in cBMA as compared to BMA (p < 0.05). Radiographic analyses of bone formation and defect bridging demonstrated significantly greater bone regeneration in the defects treated with DBM grafts as compared to Col:β-TCP grafts. The healing of bones treated with Col:β-TCP was improved when augmented with cBMA. Conclusions: Scaffolds containing either DBM or Col:β-TCP with BMA or cBMA are effective same-day strategies available to clinicians for the treatment of bone defects; the latter scaffold may be more effective if combined with cBMA.
KW - Bone marrow aspirate
KW - Demineralised bone matrix
KW - Rabbit
KW - Segmental defect
KW - Tricalcium phosphate
UR - http://www.scopus.com/inward/record.url?scp=84953635954&partnerID=8YFLogxK
U2 - 10.1007/s00264-015-2824-5
DO - 10.1007/s00264-015-2824-5
M3 - Article
C2 - 26156711
AN - SCOPUS:84953635954
SN - 0341-2695
VL - 40
SP - 197
EP - 203
JO - International Orthopaedics
JF - International Orthopaedics
IS - 1
ER -